XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Related Parties Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jun. 16, 2022
Jan. 31, 2022
Jul. 19, 2017
Feb. 24, 2015
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2019
Dec. 31, 2018
Dec. 01, 2021
Sep. 30, 2021
Jul. 01, 2021
Jul. 01, 2020
Related Parties Transactions (Details) [Line Items]                          
Current amount $ 1,000,000                        
Bears interest 5.00%                        
Working capital percentage 6.40%                        
Conversion price, description The Company may convert the Note at any time into shares of Rgene’s common stock at either (i) a fixed conversion price equal to $1.00 per share or (ii) 20% discount of the stock price of the then most recent offering, whichever is lower; the conversion price is subject to adjustment as set forth in the Note. The Note includes standard events of default, as well as a cross default provision pursuant to which a breach of the Service Agreement will trigger an event of default under the convertible note if not cured after 5 business days of written notice regarding the breach is provided.                        
Balance of outstanding loans         $ 500,000   $ 500,000            
Accrued interest         $ 19,984   13,819            
Maturity date     Jul. 18, 2019   Nov. 30, 2022                
Loan agreement total amount   $ 507,000                      
loan agreements         $ 88,091                
Interest rate   6.50%                      
Research fee         308,650.58                
Loan agreement, description                 The advances bear interest rate of 12% per annum.        
Due amount         113,863   112,822            
Outstanding advance         525,104   188,753            
Outstanding principal and accrued interest         152,848   151,450            
Interest expenses         4,896 $ 5,312              
BioFirst (Australia) [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Balance of outstanding loans         313,606   275,901            
Accrued interest         $ 1,132,070                
Due from rgene amounted                   $ 250,000     $ 361,487
Interest rate percentage                     6.50%    
Loan settled amount                       $ 67,873  
Ownership percentage         6.50%                
Research fee             1,028,556            
Jiangs [Member] | Minimum [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Ownership percentage         0.00%                
Jiangs [Member] | Maximum [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Ownership percentage         1.00%                
BHK Co Development Agreement [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Loan agreement, description       The development costs shall be shared 50/50 between BHK and the Company. Under the term of the agreement, BioLite issued relevant development cost to BHK.                  
BioFirst [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Loan agreement, description               The advances bear interest 1% per month (or equivalent to 12% per annum).          
Jiangs [Member]                          
Related Parties Transactions (Details) [Line Items]                          
Outstanding advance         $ 19,789   $ 19,789